ArticleFrontiers in medicine2026
Hematocrit and 28-day mortality in mechanically ventilated septic patients: a prospective observational study.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Sepsis is a condition that can lead to severe complications and is estimated to affect 300 million people annually. Patients requiring mechanical ventilation represent a particularly critical subgroup with high mortality. While hematocrit (HCT) has been identified as a prognostic marker in general sepsis populations, its specific role in mechanically ventilated patients remains unexplored. The objective of this study is to examine the relationship between HCT levels and 28-day mortality in this vulnerable patient cohort. Methods: In this prospective observational study, an exploratory candidate cutoff for HCT was empirically derived by maximizing the Youden index from the ROC curve to predict 28-day mortality. The cohort was then stratified into low-HCT and high-HCT groups, utilizing the aforementioned candidate threshold. To assess the stability of this data-driven cutoff, an internal bootstrap validation procedure was performed. Subsequently, the association between HCT stratification and 28-day mortality was evaluated using a Cox proportional hazards regression model, adjusting for prespecified covariates. Results: Among the 233 patients included in the study, 40 (17.2%) died within 28 days. Patients were stratified into two groups, low HCT (<26.65%) and high HCT (≥26.65%), based on the exploratory HCT cutoff of 26.65%. In the multivariable Cox proportional hazards model, patients in the low HCT group exhibited a significantly elevated risk of 28-day mortality compared to those in the high HCT group (adjusted hazard ratio [HR] = 2.16, 95% CI: 1.04-4.52; Conclusion: In this multicenter study, an exploratory HCT cutoff of 26.65% was identified, and it was observed that low HCT was associated with a 2.16-fold increased risk of 28-day mortality in mechanically ventilated sepsis patients. However, the discriminative ability of HCT was modest (AUC ≈ 0.537), suggesting limited predictive utility as a standalone test. Given its low cost and routine availability, HCT may still hold value as an adjunctive variable in risk stratification. However, further investigation is necessary to validate its incremental prognostic value and determine its optimal integration with other established predictors in larger, well-powered cohorts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.